BJDX
Income statement / Annual
Last year (2024), Bluejay Diagnostics, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Bluejay Diagnostics, Inc.'s net income was -$7.72 M.
See Bluejay Diagnostics, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$0.00 |
$249.04 K |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$200.13 K
|
$145.72 K
|
$157.04 K
|
$142.98 K
|
| Gross Profit |
$0.00
|
$0.00
|
$48.91 K
|
-$145.72 K
|
-$157.04 K
|
-$142.98 K
|
| Gross Profit Ratio |
0
|
0
|
0.2
|
0
|
0
|
0
|
| Research and Development Expenses |
$3.47 M
|
$5.71 M
|
$4.15 M
|
$1.15 M
|
$527.25 K
|
$454.61 K
|
| General & Administrative Expenses |
$3.69 M
|
$4.31 M
|
$4.76 M
|
$1.79 M
|
$596.12 K
|
$884.00 K
|
| Selling & Marketing Expenses |
$8.30 K
|
$283.44 K
|
$451.42 K
|
$289.73 K
|
$73.02 K
|
$292.80 K
|
| Selling, General & Administrative Expenses |
$3.70 M
|
$4.60 M
|
$5.21 M
|
$2.08 M
|
$669.14 K
|
$1.18 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
-$145.72 K
|
-$157.04 K
|
$0.00
|
| Operating Expenses |
$7.17 M
|
$10.31 M
|
$9.37 M
|
$3.08 M
|
$1.04 M
|
$1.63 M
|
| Cost And Expenses |
$7.17 M
|
$10.31 M
|
$9.57 M
|
$3.23 M
|
$1.20 M
|
$1.63 M
|
| Interest Income |
$145.82 K
|
$164.90 K
|
$89.67 K
|
$513.30 K
|
$143.67 K
|
$52.28 K
|
| Interest Expense |
$823.03 K
|
$0.00
|
$0.00
|
$367.46 K
|
$27.00 K
|
$0.00
|
| Depreciation & Amortization |
$199.10 K
|
$780.96 K
|
$306.37 K
|
$145.72 K
|
$157.04 K
|
$142.98 K
|
| EBITDA |
-$6.70 M |
-$9.17 M |
-$9.01 M |
-$3.08 M |
-$1.04 M |
-$1.49 M |
| EBITDA Ratio |
0
|
0
|
-36.18
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
-37.41
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$548.18 K
|
$357.33 K
|
$20.83 K
|
-$258.14 K
|
$38.11 K
|
$811.57 K
|
| Income Before Tax |
-$7.72 M
|
-$9.95 M
|
-$9.30 M
|
-$3.49 M
|
-$1.16 M
|
-$819.84 K
|
| Income Before Tax Ratio |
0
|
0
|
-37.33
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$7.72 M
|
-$9.95 M
|
-$9.30 M
|
-$3.73 M
|
-$1.13 M
|
-$757.72 K
|
| Net Income Ratio |
0
|
0
|
-37.33
|
0
|
0
|
0
|
| EPS |
-42.08 |
-72.62 |
-73.22 |
-29.67 |
-14.19 |
-9.55 |
| EPS Diluted |
-42.08 |
-72.62 |
-73.22 |
-29.67 |
-14.19 |
-9.55 |
| Weighted Average Shares Out |
$183.39 K
|
$137.06 K
|
$126.02 K
|
$125.70 K
|
$79.34 K
|
$79.34 K
|
| Weighted Average Shares Out Diluted |
$183.39 K
|
$137.06 K
|
$126.02 K
|
$125.70 K
|
$79.34 K
|
$79.34 K
|
| Link |
|
|
|
|
|
|
